Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00526123 · ClinicalTrials.gov registry record · NA

Dialysis Catheter Comparative Clinical Trial

A NA study of End Stage Renal Disease, sponsored by Tyco Healthcare Group.

Completed
Registry status
NA
Development phase
599
Enrollment target
14
Study locations

NCT00526123 is a NA study of End Stage Renal Disease that has completed, run by Tyco Healthcare Group. The registered enrollment target is 599 participants, below the 826-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (27% lower). The trial reports 14 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00526123, a NA study of End Stage Renal Disease, has completed, sponsored by Tyco Healthcare Group.

COMPLETED
Registry status
NA
Development phase
599 participants
Enrollment target
14
Study locations

Study Summary

The purpose of this clinical trial is to compare the longevity of two dialysis catheters.

Conditions Studied

End Stage Renal Disease

Interventions

  • DEVICE Symmetric Tip Catheter
  • DEVICE Conventional Split-tip Catheter

Study Locations (14)

North Carolina

  • Eastern Nephrology Associates - Greenville
  • Eastern Nephrology Associates - New Bern
  • Boice-Willis Clinic - Rocky Mount
  • Dialysis Access Group of Wake Forest University, LLC - Winston-Salem

Massachusetts

  • Tufts Medical Center - Boston
  • Massachusetts General Hospital - Boston

Pennsylvania

  • Temple University Hospital - Philadelphia
  • Nephrology Associates - Lankenau Hospital - Wynnewood

Alabama

  • Nephrology Associates, P.C. - Birmingham

Arizona

  • Southwest Kidney Institute - Phoenix

New York

  • SUNY Stony Brook Medical Center - Stony Brook

Ohio

  • Toledo Hospital - Toledo

South Carolina

  • Columbia Nephrology Associates - Columbia

Trial Details

FieldValue
Enrollment Target 599 participants
Start Date 2007-09
Est. Completion 2011-08
Phase NA

Sponsor

Tyco Healthcare Group

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00526123

The ClinicalTrials.gov registry entry for NCT00526123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 599 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 826-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (27% lower). The listed sponsor is Tyco Healthcare Group, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which Symmetric Tip Catheter is the first listed.

NCT00526123 reports 14 study locations spanning 9 distinct geographic areas - top geographies include North Carolina, Massachusetts, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00526123 about?

NCT00526123 is a clinical study titled "Dialysis Catheter Comparative Clinical Trial". The purpose of this clinical trial is to compare the longevity of two dialysis catheters.

What is the current status of trial NCT00526123?

This trial is currently completed. It is a NA study. The enrollment target is 599 participants. The study started on 2007-09. Estimated completion is 2011-08.

What conditions does trial NCT00526123 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT00526123?

The interventions under investigation include: Symmetric Tip Catheter (DEVICE), Conventional Split-tip Catheter (DEVICE).

Who is sponsoring clinical trial NCT00526123?

This trial is sponsored by Tyco Healthcare Group, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00526123 being conducted?

This trial has 14 study locations across Alabama, Arizona, Massachusetts, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.